Cargando…

The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy

Immunotherapy has revolutionized the treatment in metastatic melanoma, but alternative biomarkers that are economical, simple and reliable still need to be clarified. In this study, we aimed to comprehensively analyze the prognostic significance of baseline neutrophil-to-lymphocyte ratio (NLR) in me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yayun, Meng, Yu, Sun, Huiyan, Ye, Lin, Zeng, Furong, Chen, Xiang, Deng, Guangtong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Clinical Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654256/ https://www.ncbi.nlm.nih.gov/pubmed/34510106 http://dx.doi.org/10.1097/CJI.0000000000000392

Ejemplares similares

Pretreatment neutrophil-to-lymphocyte ratio predicts the benefit of gastric cancer patients with systemic therapy
por: Du, Songtao, et al.
Publicado: (2021)

Nomogram based on autophagy related genes for predicting the survival in melanoma
por: Deng, Guangtong, et al.
Publicado: (2021)

BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression
por: Zeng, Furong, et al.
Publicado: (2023)

Tumor neutrophils ferroptosis: a targetable immunosuppressive mechanism for cancer immunotherapy
por: Du, Songtao, et al.
Publicado: (2023)

Clinical Significance of Plasma D-Dimer in COVID-19 Mortality
por: Li, Yayun, et al.
Publicado: (2021)

Prognostic Significance of the Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Neuroendocrine Carcinoma
por: Kim, Hyeon-Jong, et al.
Publicado: (2022)

The prognostic significance of neutrophil-to-lymphocyte ratio at different time points in patients with hepatocellular carcinoma receiving liver resection
por: Dai, Tianxing, et al.
Publicado: (2020)

Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis
por: Sacdalan, Danielle Benedict, et al.
Publicado: (2018)

Prognostic significance of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with glioma
por: Wang, Junli, et al.
Publicado: (2018)

Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients
por: Ferrucci, P F, et al.
Publicado: (2015)

Prognostic values of baseline cortisol levels and neutrophil to lymphocyte ratio in COVID-19
por: Erturk, Sengel Buket, et al.
Publicado: (2023)

Prognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma
por: Lu, Aiying, et al.
Publicado: (2017)

Prognostic Potential of the Baseline Pan-Immune-Inflammation Value and Neutrophil/Lymphocyte Ratio in Stage I to III Melanoma Patients
por: Gambichler, Thilo, et al.
Publicado: (2022)

Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy
por: Henriksen, Jon Røikjær, et al.
Publicado: (2020)

Prognostic significance of the neutrophil-to-lymphocyte ratio with distal cholangiocarcinoma patients
por: Ji, Fengming, et al.
Publicado: (2020)

Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Patients With Meningiomas
por: Kuranari, Yuki, et al.
Publicado: (2020)

Neutrophil-to-lymphocyte ratio in malignant pleural fluid: Prognostic significance
por: Popowicz, Natalia, et al.
Publicado: (2021)

The prognostic significance of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in giant cell tumor of the extremities
por: Chen, Zhenhao, et al.
Publicado: (2019)

Neutrophil-to-Lymphocyte, Lymphocyte-to-Monocyte, and Platelet-to-Lymphocyte Ratios: Prognostic Significance in COVID-19
por: BG, Shivakumar, et al.
Publicado: (2021)

Baseline Neutrophil–Lymphocyte and Platelet–Lymphocyte Ratios as Biomarkers of Survival in Cutaneous Melanoma: A Multicenter Cohort Study
por: Wade, Ryckie G., et al.
Publicado: (2018)

Targeting Ferroptosis by Ubiquitin System Enzymes: A Potential Therapeutic Strategy in Cancer
por: Meng, Yu, et al.
Publicado: (2022)

Is the neutrophil-to-lymphocyte ratio a useful prognostic indicator in melanoma patients?
por: Cohen, Joshua T, et al.
Publicado: (2020)

Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients
por: Du, Songtao, et al.
Publicado: (2022)

Prognostic Implications of Metabolism Related Gene Signature in Cutaneous Melanoma
por: Zeng, Furong, et al.
Publicado: (2020)

Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in non-small cell lung cancer
por: Bayraktaroglu, Mesut, et al.
Publicado: (2023)

Clinical and prognostic significance of preoperative lymphocyte-monocyte ratio, neutrophil-lymphocyte ratio and neutrophil-monocyte ratio on esophageal squamous cell carcinoma patients
por: Shang, Qi-Xin, et al.
Publicado: (2020)

Prognostic and clinicopathological significance of neutrophil-to-lymphocyte ratio in patients with oral cancer
por: Yang, Yun, et al.
Publicado: (2018)

Prognostic significance of neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma
por: Sakin, Aysegul, et al.
Publicado: (2021)

Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in surgically resected schwannomas
por: Takahara, Kento, et al.
Publicado: (2023)

Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer
por: Zhao, Guanghui, et al.
Publicado: (2020)

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
por: Wang, Jing-Houng, et al.
Publicado: (2022)

The Prognostic Significance of Sarcopenia and the Neutrophil-to-Lymphocyte Ratio in Elderly Patients with Esophageal Squamous Cell Carcinoma
por: Peng, Huajian, et al.
Publicado: (2021)

Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer
por: Kim, Jae Hyun, et al.
Publicado: (2017)

Prognostic Value of Neutrophil–Lymphocyte Ratio, Platelet–Lymphocyte Ratio, and Combined Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Stage IV Advanced Gastric Cancer
por: Wang, Huan, et al.
Publicado: (2020)

Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis
por: Xiao, Wei-Kai, et al.
Publicado: (2014)

Prognostic significance of neutrophil-to- lymphocyte ratio in esophageal cancer: a meta-analysis
por: Yang, Xun, et al.
Publicado: (2015)

Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer
por: Chen, Z-Y, et al.
Publicado: (2015)

Prognostic Significance of Neutrophil-to-Lymphocyte Ratio for Repeat Cerclage in Women with Prolapsed Membranes
por: Song, Ji Eun, et al.
Publicado: (2018)

Prognostic significance of neutrophil-to-lymphocyte ratio in rectal cancer: a meta-analysis
por: Dong, Yi-wei, et al.
Publicado: (2016)

Prognostic Significance of Neutrophil/Lymphocytes Ratio (NLR) in Predicting Recurrence of Cervical Dysplasia
por: Origoni, Massimo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j7gptng83p8mn29hmkrpstljen